Coincidence of diabetes mellitus and hypertension in a semi-urban Cameroonian population: a cross-sectional study

BMC Public Health

Andre-Pascal Kengne¹  Charles Kouam Kouam³  Gerard Tama Fetse³  Eta N Mbong⁴  Eugene Sobngwi²  Anastase Dzudie⁵  Jean-Claude Katte³ 

[1] Non-Communicable Diseases Research Unit, South African Medical Research Council, PO Box 19070, Tygerberg, Cape Town 7505, South Africa;Department of Internal Medicine and Subspecialties, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon;Regional Hospital of Bafoussam, Ministry of Public Health, Bafoussam, Cameroon;Ministry of Public Health, Yaounde, Cameroon;Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

关键词: Cameroon;    Sub-Saharan Africa;    Prevalence;    Coincidence;    Diabetes mellitus;    Hypertension;   

Others  :  866300
DOI  :  10.1186/1471-2458-14-696

 received in 2014-03-25, accepted in 2014-07-02,  发布年份 2014

【 摘 要 】

Background

Hypertension and diabetes mellitus are increasingly common in population within Africa. We determined the rate of coincident diabetes and hypertension and assessed the levels of co-awareness, treatment and control in a semi-urban population in Cameroon.

Methods

A total of 1702 adults (967 women) self-selected from the community were consecutively recruited in Bafoussam (West region of Cameroon) during November 2012. Existing diabetes and hypertension and treatments were investigated and blood pressure and fasting blood glucose measured. Multinomial logistic regressions models were used to investigate the determinants of prevalent diabetes and hypertension.

Results

Age-standardized prevalence rates (95% confidence intervals) men vs. women were 40.4% (34.7 to 46.1) and 23.8% (20.4 to 27.2) for hypertension alone; 3.3% (1.5 to 5.1) and 5.6% (3.5 to 7.7) for diabetes alone; and 3.9% (2.6 to 5.2) and 5.0% (3.5 to 6.5) for hypertension and diabetes. The age-standardized awareness, treatment and control rates for hypertension alone were 6.5%, 86.4% and 37.2% for men, and 24.3%, 52.1% and 51.6% in women. Equivalent figures for diabetes alone were 35.4%, 65.6% and 23.1% in men and 26.4%, 75.5% and 33.7% in women; and those for hypertension and diabetes were 86.6%, 3.3% and 0% in men, and 74.7%, 22.6% and 0% in women. Sex, age and adiposity were the main determinants of the three conditions.

Conclusions

Coincident diabetes and hypertension is as high as diabetes alone in this population, driven by sex, age and adiposity. Awareness, treatment and control remain unacceptably low.

【 授权许可】

   
2014 Katte et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]International Diabetes F: IDF Diabetes Atlas. 5th edition. Brussels, Belgium: International Diabetes Federation; 2011. http://www.idf.org/sites/default/files/5E_IDFAtlasPoster_2012_EN.pdf webcite
• [2]Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365(9455):217-223.
• [3]Mensah GA: The global burden of hypertension: good news and bad news. Cardiol Clin 2002, 20(2):181-185.
• [4]UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998, 317(7160):703-713.
• [5]Mufunda J, Chatora R, Ndambakuwa Y, Nyarango P, Kosia A, Chifamba J, Filipe A, Usman A, Sparks VH: Emerging non-communicable disease epidemic in Africa: preventive measures from the WHO Regional Office for Africa. Ethn Dis 2006, 16(2):521-526.
• [6]Lago RM, Singh PP, Nesto RW: Diabetes and hypertension. Nat Clin Pract Endocrinol Metab 2007, 3(10):667.
• [7]Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993, 16(2):434-444.
• [8]Amin SP, Mullins CD, Duncan BS, Blandford L: Direct health care costs for treatment of diabetes mellitus and hypertension in an IPA-group-model HMO. Am J Health Syst Pharm 1999, 56(15):1515-1520.
• [9]Fezeu L, Kengne AP, Balkau B, Awah PK, Mbanya JC: Ten-year change in blood pressure levels and prevalence of hypertension in urban and rural Cameroon. J Epidemiol Community Health 2010, 64(4):360-365.
• [10]Assah FK, Mbanya JC: Diabetes in sub-Saharan Africa - overview of a looming health challenge. Eur Endocrinol 2009, 5(1):13-17.
• [11]Mbanya JC, Kengne AP, Assah F: Diabetes care in Africa. Lancet 2006, 368(9548):1628-1629.
• [12]Kamadjeu RM, Edwards R, Atanga JS, Unwin N, Kiawi EC, Mbanya JC: Prevalence, awareness and management of hypertension in Cameroon: findings of the 2003 Cameroon Burden of Diabetes Baseline Survey. J Hum Hypertens 2006, 20(1):91-92.
• [13]Cameroon's National Institute of Statistics: Statistical Yearbook 2010. 2011, 39-52.
• [14]Population du Cameroun en 2010 http://www.statistics-cameroon.org/downloads/La_population_du_Cameroun_2010.pdf webcite
• [15]World Health Organization: Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organ Tech Rep Ser 1995, 854:1-452.
• [16]Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003, 289(19):2560-2572.
• [17]Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120(16):1640-1645.
• [18]Woodward M (Ed): Epidemiology: Study Design and Data Analysis. 2nd edition. New York: Chapman & Hall/CRC; 2005.
• [19]Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL: Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis risk in communities study. N Engl J Med 2000, 342(13):905-912.
• [20]Bell DS: Hypertension and diabetes: a toxic combination. Endocr Pract 2008, 14(8):1031-1039.
• [21]Choukem SP, Kengne AP, Dehayem YM, Simo NL, Mbanya JC: Hypertension in people with diabetes in sub-Saharan Africa: revealing the hidden face of the iceberg. Diabetes Res Clin Pract 2007, 77(2):293-299.
• [22]Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR: Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000, 321(7258):412-419.
• [23]Gagliardino JJ, Olivera EM, Barragan H, Hernandez RE: [Diabetes mellitus and hypertension, clinical and epidemiological aspects in the population of La Plata]. Medicina 1995, 55(5 Pt 1):421-430.
• [24]Dzudie A, Kengne AP, Muna WF, Ba H, Menanga A, Kouam Kouam C, Abah J, Monkam Y, Biholong C, Mintom P, Kamdem F, Djomou A, Ndjebet J, Wambo C, Luma H, Ngu KB, Kingue S, CCS investigator group: Prevalence, awareness, treatment and control of hypertension in a self-selected sub-Saharan African urban population: a cross-sectional study. BMJ Open 2012., 2(4)
• [25]Echouffo-Tcheugui JB, Kengne AP: Chronic non-communicable diseases in Cameroon - burden, determinants and current policies. Glob Health 2011, 7(1):44. BioMed Central Full Text
• [26]Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, et al.: 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25(6):1105-1187.